 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Atea Pharmaceuticals Inc. (AVIR)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-11-03 Purchase | 2020-11-03 8:09 pm | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 41,666 | $24 | $999,984 | 820,019 (Direct) | View |
| 2020-11-03 Purchase | 2020-11-03 9:36 pm | Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director | 250,000 | $24 | $6,000,000 | 5,615,659 (Indirect) | View |
| 2020-11-03 Purchase | 2020-11-04 4:05 pm | Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 250,000 | $24 | $6,000,000 | 289,695 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-10-29 Option Award | 2020-10-30 5:18 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:39 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Cheng Isaac Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:40 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks | 40,000 | $0 | 40,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:41 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:43 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:47 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-10-29 Option Award | 2020-10-30 5:49 pm | N/A 2030-10-28 | Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:04 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 82,508 | $0 | 82,508 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 8:04 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 82,508 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 8:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Chu Chung K. 10% Owner | 176,862 | $0 | 1,176,862 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Chu Chung K. 10% Owner | 100,000 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Chu Chung K. 10% Owner | 33,003 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Chu Chung K. 10% Owner | 43,859 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:08 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre CEO Chairman | 750,000 | $0 | 5,925,000 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 8:08 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre CEO Chairman | 750,000 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 8:08 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 133,004 | $0 | 633,004 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:08 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 100,000 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:08 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 33,004 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 759,606 | $0 | 778,353 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 400,000 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 132,014 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 131,578 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 60,540 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director | 35,474 | $0 | 0 (Direct) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 11,295 | $0 | 11,295 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 7,122 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 8:09 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director | 4,173 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 9:36 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director | 5,365,659 | $0 | 5,365,659 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 9:36 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director | 3,383,190 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-03 9:36 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director | 1,982,469 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-04 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 1,412,016 | $0 | 1,412,016 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-04 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 282,403 | $0 | 282,403 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-04 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 890,313 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-04 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 521,703 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-04 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 178,063 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-04 4:05 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner | 104,340 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-05 4:01 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Cormorant Asset Management LP Chen Bihua Cormorant Private Healthcare Fund II LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Former 10% Owner | 6,411,355 | $0 | 6,411,355 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-05 4:01 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Cormorant Asset Management LP Chen Bihua Cormorant Private Healthcare Fund II LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Former 10% Owner | 1,000,000 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-05 4:01 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Cormorant Asset Management LP Chen Bihua Cormorant Private Healthcare Fund II LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Former 10% Owner | 1,650,165 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-05 4:01 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Cormorant Asset Management LP Chen Bihua Cormorant Private Healthcare Fund II LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Former 10% Owner | 2,631,580 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-05 4:01 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Cormorant Asset Management LP Chen Bihua Cormorant Private Healthcare Fund II LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Former 10% Owner | 712,250 | $0 | 0 (Indirect) | View |
| 2020-11-03 Conversion | 2020-11-05 4:01 pm | N/A N/A | Atea Pharmaceuticals Inc. | AVIR | Cormorant Asset Management LP Chen Bihua Cormorant Private Healthcare Fund II LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Former 10% Owner | 417,360 | $0 | 0 (Indirect) | View |
| 2021-01-29 Option Award | 2021-02-01 4:50 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks | 71,750 | $0 | 71,750 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:51 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer | 145,500 | $0 | 145,500 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:51 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer | 117,300 | $0 | 117,300 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:52 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks | 148,850 | $0 | 148,850 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:55 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer | 160,050 | $0 | 160,050 (Direct) | View |
| 2021-01-29 Option Award | 2021-02-01 4:56 pm | N/A 2031-01-28 | Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre CEO Chairman | 640,000 | $0 | 640,000 (Direct) | View |